Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Cellectar Biosciences, Inc. (NASDAQ: CLRB) | Delayed: 1.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.78 | 52 Week High | $6.03 | |||
| Open | $1.78 | 52 Week Low | $0.41 | |||
| Day High | $1.78 | P/E | N/A | |||
| Day Low | $1.78 | EPS | $0.00 | |||
| Volume | 15 | |||||
